Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001564590-16-021569
Filing Date
2016-07-27
Accepted
2016-07-27 10:04:09
Documents
27

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2754780
2 filename2.htm EX-3 163030
3 filename3.htm EX-4 126263
4 filename4.htm EX-10 144457
5 filename5.htm EX-10 89822
6 filename6.htm EX-10 80157
7 filename7.htm EX-10 28575
8 filename8.htm EX-10 294439
9 filename9.htm EX-21 1539
10 GRAPHIC g125525g44k82.jpg GRAPHIC 44969
11 GRAPHIC g125525g44r56.jpg GRAPHIC 32021
12 GRAPHIC g125525g56y02.jpg GRAPHIC 87845
13 GRAPHIC g125525g70w68.jpg GRAPHIC 87150
14 GRAPHIC g125525g84x78.jpg GRAPHIC 22460
15 GRAPHIC g125525g85x08.jpg GRAPHIC 3188
16 GRAPHIC g125525g89x15.jpg GRAPHIC 31448
17 GRAPHIC g183927g21w10.jpg GRAPHIC 33374
18 GRAPHIC g183927g28n12.jpg GRAPHIC 47260
19 GRAPHIC g183927g42b53.jpg GRAPHIC 52782
20 GRAPHIC g183927g46v89.jpg GRAPHIC 105238
21 GRAPHIC g183927g50u51.jpg GRAPHIC 42520
22 GRAPHIC g183927g77f17.jpg GRAPHIC 84416
23 GRAPHIC g183927g80c75.jpg GRAPHIC 52173
24 GRAPHIC g183927g84b16.jpg GRAPHIC 34581
25 GRAPHIC g183927g87t50.jpg GRAPHIC 104996
26 GRAPHIC g183927g89g09.jpg GRAPHIC 49389
27 filename27.htm COVER 30113
  Complete submission text file 0001564590-16-021569.txt   4974199
Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01325 | Film No.: 161785857
SIC: 2836 Biological Products, (No Diagnostic Substances)